Analysts who follow 10X Genomics Inc (TXG) on average expect it to add 5.97% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns TXG an Analyst Ranking of 31, which means it ranks higher than 31 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating TXG a Buy today. Find out what this means to you and get the rest of the rankings on TXG!